Evidence map›Paper›PMID 32804075›Full record

ArticleeLife2020

Sonia Stefanovic, Brigitte Laforest, Jean-Pierre Desvignes, Fabienne Lescroart, Laurent Argiro, Corinne Maurel-Zaffran, David Salgado, Elise Plaindoux, Christopher De Bono, Kristijan Pazur and 6 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 58 citations in OpenAlex.

  1. An Outflow Tract Myocardium-Specific Enhancer at the Sema3c Locus During Heart Development.Genes to cells : devoted to molecular & cellular mechanisms · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Cardiac Progenitor Cells of the First and Second Heart Fields.Advances in experimental medicine and biology · 2024
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  17. Article
  18. Biology · 2023
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Sonia Stefanovic *Aix Marseille Univ, INSERM, Marseille Medical Genetics, Marseille, France.
Brigitte Laforest *Aix Marseille Univ, INSERM, Marseille Medical Genetics, Marseille, France.ORCID 0000-0001-6919-8922
Jean-Pierre DesvignesAix Marseille Univ, INSERM, Marseille Medical Genetics, Marseille, France.
Fabienne LescroartAix Marseille Univ, INSERM, Marseille Medical Genetics, Marseille, France.ORCID 0000-0003-4942-7921
Laurent ArgiroAix Marseille Univ, INSERM, Marseille Medical Genetics, Marseille, France.
Corinne Maurel-ZaffranAix Marseille Univ, CNRS UMR7288, IBDM, Marseille, France.
David SalgadoAix Marseille Univ, INSERM, Marseille Medical Genetics, Marseille, France.
Elise PlaindouxAix Marseille Univ, INSERM, Marseille Medical Genetics, Marseille, France.
Christopher De BonoAix Marseille Univ, CNRS UMR7288, IBDM, Marseille, France.
Kristijan PazurPaul Langerhans Institute Dresden (PLID) of Helmholtz Center Munich at the University Clinic Carl Gustave Carus of TU Dresden, Helmoholtz Zentrum München, German Center for Diabetes Research (DZD), Dresden, Germany.
Magali Théveniau-RuissyAix Marseille Univ, INSERM, Marseille Medical Genetics, Marseille, France.ORCID 0000-0002-7346-7096
Christophe BéroudAix Marseille Univ, INSERM, Marseille Medical Genetics, Marseille, France.
Michel PuceatAix Marseille Univ, INSERM, Marseille Medical Genetics, Marseille, France.ORCID 0000-0001-9055-7563
Anthony GavalasPaul Langerhans Institute Dresden (PLID) of Helmholtz Center Munich at the University Clinic Carl Gustave Carus of TU Dresden, Helmoholtz Zentrum München, German Center for Diabetes Research (DZD), Dresden, Germany.
Robert G KellyAix Marseille Univ, CNRS UMR7288, IBDM, Marseille, France.
Stephane ZaffranAix Marseille Univ, INSERM, Marseille Medical Genetics, Marseille, France.ORCID 0000-0002-0811-418X
Inserm · FRCentre National de la Recherche Scientifique · FRDeutsches Diabetes-Zentrum e.V. · DE

Funding

Agence Nationale de la Recherche ANR-13-BSV2-0003Agence Nationale de la Recherche ANR-18-CE13-0011Association Française contre les Myopathies MNH-DecryptEuropean Commission H2020-MSCA-IF-2014Fondation pour la Recherche Médicale DEQ20150331717
6 · The paper itself

Abstract

Perturbation of addition of second heart field (SHF) cardiac progenitor cells to the poles of the heart tube results in congenital heart defects (CHD). The transcriptional programs and upstream regulatory events operating in different subpopulations of the SHF remain unclear. Here, we profile the transcriptome and chromatin accessibility of anterior and posterior SHF sub-populations at genome-wide levels and demonstrate that Hoxb1 negatively regulates differentiation in the posterior SHF. Spatial mis-expression of

Indexed as

TranscriptomeAnimalsChromatinGenes, HomeoboxHeart Defects, CongenitalHomeodomain ProteinsMiceMice, TransgenicStem CellsChromatinHomeodomain ProteinsHOXB1 homeodomain proteincardiac differentiationcongenital heart defectdevelopmental biologyheart developmentHoxmouseprogenitor cellSHF

Identifiers

PMID32804075
PMCPMC7462617
OpenAlexW3074354799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.